X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (32) 32
humans (28) 28
uganda (24) 24
infectious diseases (21) 21
female (20) 20
male (20) 20
hiv infections - drug therapy (18) 18
hiv (17) 17
adult (16) 16
antiretroviral therapy (14) 14
human immunodeficiency virus--hiv (12) 12
immunology (12) 12
adolescent (11) 11
adults (11) 11
africa (11) 11
hiv infection (10) 10
middle aged (10) 10
uganda - epidemiology (10) 10
anti-hiv agents - therapeutic use (9) 9
highly active antiretroviral therapy (9) 9
hiv infections - epidemiology (9) 9
hiv infections - virology (9) 9
young adult (9) 9
antiviral agents (8) 8
child (8) 8
drug therapy (8) 8
multidisciplinary sciences (8) 8
aids (7) 7
article (7) 7
cd4 lymphocyte count (7) 7
child, preschool (7) 7
hiv-1 - drug effects (7) 7
phylogeny (7) 7
research article (7) 7
sub-saharan africa (7) 7
treatment outcome (7) 7
virology (7) 7
acquired immune deficiency syndrome--aids (6) 6
animals (6) 6
antiretroviral drugs (6) 6
care and treatment (6) 6
cross-sectional studies (6) 6
human immunodeficiency virus (6) 6
infection (6) 6
medicine (6) 6
microbiology (6) 6
mutation (6) 6
prevalence (6) 6
resource-limited settings (6) 6
risk (6) 6
therapy (6) 6
adherence (5) 5
age (5) 5
aids/hiv (5) 5
antiretroviral agents (5) 5
antiretroviral therapy, highly active (5) 5
children (5) 5
cohort (5) 5
drug resistance (5) 5
drug resistance, viral (5) 5
genotype (5) 5
hiv infections - immunology (5) 5
hiv-1 - genetics (5) 5
retrospective studies (5) 5
science (5) 5
usage (5) 5
viral load (5) 5
viruses (5) 5
anti-retroviral agents - therapeutic use (4) 4
cd4 antigen (4) 4
clinical trials (4) 4
diversity (4) 4
efficacy (4) 4
epidemiology (4) 4
hiv-1 (4) 4
infectious disease (4) 4
medical research (4) 4
miocene (4) 4
mutations (4) 4
outcomes (4) 4
patient outcomes (4) 4
prevention (4) 4
regimens (4) 4
research (4) 4
reverse-transcriptase (4) 4
rheumatic heart disease (4) 4
surveillance (4) 4
acquired immune deficiency syndrome (3) 3
age factors (3) 3
aged (3) 3
analysis (3) 3
anti-hiv agents (3) 3
anti-retroviral agents - administration & dosage (3) 3
antiretroviral treatment (3) 3
behavior (3) 3
body mass index (3) 3
body size (3) 3
cohort studies (3) 3
confidence intervals (3) 3
disease progression (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Amarasinghe, Gaya K and Aréchiga Ceballos, Nidia G and Banyard, Ashley C and Basler, Christopher F and Bavari, Sina and Bennett, Andrew J and Blasdell, Kim R and Briese, Thomas and Bukreyev, Alexander and Caì, Yíngyún and Calisher, Charles H and Campos Lawson, Cristine and Chandran, Kartik and Chapman, Colin A and Chiu, Charles Y and Choi, Kang-Seuk and Collins, Peter L and Dietzgen, Ralf G and Dolja, Valerian V and Dolnik, Olga and Domier, Leslie L and Dürrwald, Ralf and Dye, John M and Easton, Andrew J and Ebihara, Hideki and Echevarría, Juan E and Fooks, Anthony R and Formenty, Pierre B. H and Fouchier, Ron A. M and Freuling, Conrad M and Ghedin, Elodie and Goldberg, Tony L and Hewson, Roger and Horie, Masayuki and Hyndman, Timothy H and Jiāng, Dàohóng and Kityo, Robert and Kobinger, Gary P and Kondō, Hideki and Koonin, Eugene V and Krupovic, Mart and Kurath, Gael and Lamb, Robert A and Lee, Benhur and Leroy, Eric M and Maes, Piet and Maisner, Andrea and Marston, Denise A and Mor, Sunil Kumar and Müller, Thomas and Mühlberger, Elke and Ramírez, Víctor Manuel Neira and Netesov, Sergey V and Ng, Terry Fei Fan and Nowotny, Norbert and Palacios, Gustavo and Patterson, Jean L and Pawęska, Janusz T and Payne, Susan L and Prieto, Karla and Rima, Bertus K and Rota, Paul and Rubbenstroth, Dennis and Schwemmle, Martin and Siddell, Stuart and Smither, Sophie J and Song, Qisheng and Song, Timothy and Stenglein, Mark D and Stone, David M and Takada, Ayato and Tesh, Robert B and Thomazelli, Luciano Matsumiya and Tomonaga, Keizō and Tordo, Noël and Towner, Jonathan S and Vasilakis, Nikos and Vázquez-Morón, Sonia and Verdugo, Claudio and Volchkov, Viktor E and Wahl, Victoria and Walker, Peter J and Wang, David and Wang, Lin-Fa and Wellehan, James F. X and Wiley, Michael R and Whitfield, Anna E and Wolf, Yuri I and Yè, Gōngyín and Zhāng, Yǒng-Zhèn and Kuhn, Jens H
Archives of Virology, ISSN 0304-8608, 8/2018, Volume 163, Issue 8, pp. 2283 - 2294
Journal Article
Nature communications, ISSN 2041-1723, 03/2019, Volume 10, Issue 1, pp. 1411 - 13
To prevent new infections with human immunodeficiency virus type 1 (HIV-1) in sub-Saharan Africa, UNAIDS recommends targeting interventions to populations that... 
HETEROGENEITY | AMPLIFICATION | RECONSTRUCTION | MULTIDISCIPLINARY SCIENCES | DISEASE | GENERALIZED EPIDEMICS | RISK | DIVERSITY | INFECTION | TYPE-1 | UGANDA | Epidemics | Networks | Disease transmission | Populations | Human immunodeficiency virus--HIV | Phylogenetics | Viruses | Phylogeny
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2009, Volume 106, Issue 33, pp. 13903 - 13908
Journal Article
Viruses, ISSN 1999-4915, 03/2019, Volume 11, Issue 3, p. 209
While serological and virological evidence documents the exposure of bats to medically-important arboviruses, their role as reservoirs or amplifying hosts is... 
orbivirus | surveillance | bat | next-generation sequencing | Reoviridae | arbovirus | COMPLETE SEQUENCE | ALGORITHM | IFE | GENOME | VIROLOGY | ALIGNMENT | MODELS | KEMEROVO | INFECTION | REASSORTMENT
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, p. e76158
Journal Article
PLoS medicine, ISSN 1549-1676, 12/2018, Volume 15, Issue 12, p. e1002706
Background In sub-Saharan Africa, individuals infected with HIV who are severely immunocompromised have high mortality (about 10%) shortly after starting... 
MORTALITY | BIOMARKERS | SOUTH-AFRICA | MEDICINE, GENERAL & INTERNAL | IMMUNE RECONSTITUTION | EFAVIRENZ | ADULTS | INFECTION | RESTORATION | IMMUNODEFICIENCY | CHILDREN | HIV Infections - diagnostic imaging | Africa - epidemiology | Zimbabwe - epidemiology | Drug Administration Schedule | Follow-Up Studies | Kenya - epidemiology | HIV Infections - epidemiology | Humans | Raltegravir Potassium - administration & dosage | Child, Preschool | Malawi - epidemiology | Uganda - epidemiology | Male | Disease Progression | Anti-HIV Agents - administration & dosage | Young Adult | Anti-Retroviral Agents - administration & dosage | Adolescent | Adult | Female | HIV Infections - drug therapy | Child | Health Services Accessibility - trends | Drug therapy | HIV infection | Raltegravir | Testing | Adolescence | Therapy | RNA-directed DNA polymerase | Viremia | Funding | Clinical trials | Risk | Viruses | Infections | Tenofovir | Randomization | Motivation | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Children | Adolescents | Genotypes | Supervision | University colleges | Integrase | Antiretroviral drugs | Medical research | Mortality | Immune reconstitution | Inflammation | Disease control | Antiretroviral therapy | Morbidity | CD4 antigen | Medicine | Amplification | Non-nucleoside reverse transcriptase inhibitors | Inhibitors | Councils | Abacavir | Nucleosides | Biomarkers | Mutation | HIV | Human immunodeficiency virus
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2013, Volume 8, Issue 2, p. e57028
Journal Article
by Hakim, James G and Thompson, Jennifer and Kityo, Cissy and Hoppe, Anne and Kambugu, Andrew and van Oosterhout, Joep J and Lugemwa, Abbas and Siika, Abraham and Mwebaze, Raymond and Mweemba, Aggrey and Abongomera, George and Thomason, Margaret J and Easterbrook, Philippa and Mugyenyi, Peter and Walker, A Sarah and Paton, Nicholas I and Agweng, E and Awio, P and Bakeinyaga, G and Isabirye, C and Kabuga, U and Kasuswa, S and Katuramu, M and Kiweewa, F and Kyomugisha, H and Lutalo, E and Mulima, D and Musana, H and Musitwa, G and Musiime, V and Ndigendawan, M and Namata, H and Nkalubo, J and Labejja, P Ocitti and Okello, P and Olal, P and Pimundu, G and Segonga, P and Ssali, F and Tamale, Z and Tumukunde, D and Namala, W and Byaruhanga, R and Kayiwa, J and Tukamushaba, J and Abunyang, S and Eram, D and Denis, O and Lwalanda, R and Mugarura, L and Namusanje, J and Nankya, I and Nankya, A and Ndashimye, E and Nabulime, E and Senfuma, O and Bihabwa, G and Buluma, E and Elbireer, A and Kamya, D and Katwere, M and Kiggundu, R and Komujuni, C and Laker, E and Lubwama, E and Mambule, I and Matovu, J and Nakajubi, A and Nakku, J and Nalumenya, R and Namuyimbwa, L and Semitala, F and Wandera, B and Wanyama, J and Mugerwa, H and Ninsiima, E and Ssenkindu, T and Mwebe, S and Atwine, L and William, H and Katemba, C and Acaku, M and Ssebutinde, P and Kitizo, H and Kukundakwe, J and Naluguza, M and Ssegawa, K and Namayanja and Nsibuka, F and Tuhirirwe, P and Fortunate, M and Acen, J and Achidri, J and Amone, A and Amone, G and Chamai, M and Ditai, J and Kemigisa, M and Kiconco, M and Matama, C and ... and Europe Africa Res Network and Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
The Lancet Infectious Diseases, ISSN 1473-3099, 01/2018, Volume 18, Issue 1, pp. 47 - 57
Journal Article